ConductScience.org, home

Paper833869

IgG4 subclass in malignant melanoma.

Daveau M and 7 others. J Natl Cancer Inst, 1977. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. IgG4 subclass in malignant melanoma. Papers, record 833869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/833869

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IgG4 subclass in malignant melanoma.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2020-12-22
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daveau MM
2Pavie-Fischer JJ
3Rivat LL
4Rivat CC
5Ropartz CC
6Peter HHH H
7Cesarini JPJ P
8Kourilsky FMF M

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunoglobulin GMajor topic
MelanomaMajor topic
Skin NeoplasmsMajor topic
Female
Humans
Immunoglobulin Allotypes
Male

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
41954969Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms.Oncotarget2026https://conductscience.org/library/papers/41954969PubMed
40977881IMGT® analysis of the human IGH locus: unveiling novel polymorphisms and copy number variations in 15 genome assemblies from diverse ancestral backgrounds.NAR Genom Bioinform2025https://conductscience.org/library/papers/40977881PubMed
40592566The dual role of IgG4 in immunity: bridging pathophysiology and therapeutic applications.Gut2025https://conductscience.org/library/papers/40592566PubMed
40484866Adaptive immune changes in colorectal cancer: a focus on T and B cell activation genes.Discov Oncol2025https://conductscience.org/library/papers/40484866PubMed
40449958Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma.J Immunother Cancer2025https://conductscience.org/library/papers/40449958PubMed
40358163Role of IgG4 Antibodies in Human Health and Disease.Cells2025https://conductscience.org/library/papers/40358163PubMed
37652365Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.Biochim Biophys Acta Gen Subj2023https://conductscience.org/library/papers/37652365PubMed
37243095IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein.Vaccines (Basel)2023https://conductscience.org/library/papers/37243095PubMed
37095254The unique properties of IgG4 and its roles in health and disease.Nat Rev Immunol2023https://conductscience.org/library/papers/37095254PubMed
36211808Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies.Oncoimmunology2022https://conductscience.org/library/papers/36211808PubMed
35218154A B-cell or a key player? The different roles of B-cells and antibodies in melanoma.Pigment Cell Melanoma Res2022https://conductscience.org/library/papers/35218154PubMed
34725991Intracranial Tumors Associated With IgG4-Related Disease.Brain Tumor Res Treat2021https://conductscience.org/library/papers/34725991PubMed
34382595Lung adenocarcinoma misdiagnosed as IgG4-related lung disease: A case report and literature review.Zhong Nan Da Xue Xue Bao Yi Xue Ban2021https://conductscience.org/library/papers/34382595PubMed
33753489Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/33753489PubMed
33569063B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies.Front Immunol2020https://conductscience.org/library/papers/33569063PubMed
31737561Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study.Front Oncol2019https://conductscience.org/library/papers/31737561PubMed
29377160IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.Ann N Y Acad Sci2018https://conductscience.org/library/papers/29377160PubMed
27222052Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models.Cancer Immunol Immunother2016https://conductscience.org/library/papers/27222052PubMed
26951261A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis.Virchows Arch2016https://conductscience.org/library/papers/26951261PubMed
26742760IgG4 Characteristics and Functions in Cancer Immunity.Curr Allergy Asthma Rep2016https://conductscience.org/library/papers/26742760PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/833869

GET https://conductscience.org/api/papers/v1/833869/cited_by?page=2